Applications provider 2Morrow and the Aplastic Anemia & MDS International Foundation have developed a mobile resource for aplastic anemia patients and their families. The app will allow patients to track how their bodies respond to therapy. "This first version of the app will test the waters and be used as a learning experience. If patients find it useful, we may go back and add more features including things like EHR integration and some behavior change tools," 2Morrow Chief Operating Officer Jo Masterson said.
Published in Brief: